Congress often has a reputation for not getting anything done, or worse, passing misguided policies that many Americans reject. We can debate the merits of both perceptions, but the frustration ...

Gain insights into Lexicon Pharmaceuticals' Q2 2025 earnings call including R&D progress, cost savings, partnership updates, and a shift to net profitability.